JASPERS HEALTH LIMITEDActive

Company number 08116450Private limited companyIncorporated 2012

Key figures

£586,567+9.7%
Net assets 2024/25
+29.7%
Average annual growth 2019/20–2024/25
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, JASPERS HEALTH LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand29,135144,07213,09838,24041,625
Total assets1,124,9631,150,5422,628,1493,002,6973,603,042
Total liabilities886,537784,7022,136,2882,468,1023,016,475
Net assets / total equity238,426365,840491,861534,595586,567
Average number of employees91501118

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: JASPERS HEALTH LIMITED

Company

JASPERS HEALTH LIMITED is a private limited company registered with Companies House under company number 08116450. It was incorporated on 22 Jun 2012. Its status is active. The registered office is in Croydon (CR0). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files abridged accounts (unaudited). Net assets were £586,567, up 9.7% on the previous year. Cash at bank and in hand was £41,625. Total assets were £3,603,042 and total liabilities £3,016,475. The company had an average of 18 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 4 of 7 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 16 Sep 2027.